Weblogic Authors: Yeshim Deniz, Elizabeth White, Michael Meiner, Michael Bushong, Avi Rosenthal

News Feed Item

Millions of Americans Turn to Web Site to Learn About Fake, Counterfeit Drugs

Millions of Americans Turn to Web Site to Learn About Fake, Counterfeit Drugs

WASHINGTON, July 6 /PRNewswire/ -- More than six million consumers have logged on to BuySafeDrugs.info over the last year to learn about the risks associated with fake and counterfeit medicines. The Web site, sponsored by the Pharmaceutical Research Manufacturers of America (PhRMA), was launched June 21, 2005, and is the first online clearinghouse of information on the potential dangers of buying medicines outside of the secure U.S. drug delivery system.

"When we launched the site, our goal was to educate and inform patients about the growing problem of fake, substandard and counterfeit drugs imported into the United States. Since then, BuySafeDrugs.info and the number of people visiting it have grown tremendously. This demonstrates the need to provide patients with reliable information on how to identify potential problems so they are armed to make smart decisions about where to get their medicines," said Ken Johnson, senior vice president of PhRMA.

In the year since the Web site's launch, numerous federal and international authorities have weighed in on the dangers of illegal importation and counterfeiting, including the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA) and the World Health Organization (WHO). In December, an FDA operation found that nearly half of the imported drugs they intercepted from four selected countries were shipped to fill orders that consumers believed they were placing with "Canadian" pharmacies. A number of these products were found to be counterfeit. On June 4, NBC News's "Dateline," aired a stunning expose into the growing international problem of counterfeit prescription drugs.

The Center for Medicines in the Public Interest predicts that counterfeit drug sales will reach $75 billion globally in 2010, an increase of more than 90 percent from last year. According to WHO, the consequences of accidentally taking counterfeit medicines can be serious, leading to therapeutic failure or drug resistance, and in some cases, even death.

"When people can't afford their prescriptions, they should not be directed to foreign countries where unsafe and counterfeit drugs have been found," said Johnson. "This site not only educates consumers about the potential dangers associated with imported medicines, but also puts them in touch with resources that can help them safely save on their prescription drugs."

More than 475 assistance programs are available now to help through the Partnership for Prescription Assistance (http://www.pparx.org/ or 1-888-4PPA- NOW). To date, the PPA has matched nearly 2.5 million patients to programs that can provide free or nearly free medications.

The new Medicare prescription drug program is also offering a safe, legal alternative to beneficiaries looking to save on their medicines. A recent AARP study found many seniors will save more through Medicare's new drug program than through illegal importation schemes. The typical senior who previously lacked drug coverage will save $1,100 annually on their prescription drugs through the new Medicare plan, according to this study.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $39.4 billion in 2005 in discovering and developing new medicines. Industry- wide research and investment reached a record $51.3 billion in 2005.

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info/

PhRMA Internet Address: http://www.phrma.org/

For information on how innovative medicines save lives, visit: http://www.innovation.org/

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org/

Pharmaceutical Research Manufacturers of America

CONTACT: Wanda Moebius of the Pharmaceutical Research Manufacturers of
America, +1-202-835-3460

Web site: http://www.phrma.org/

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence. Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busine...
Whenever a new technology hits the high points of hype, everyone starts talking about it like it will solve all their business problems. Blockchain is one of those technologies. According to Gartner's latest report on the hype cycle of emerging technologies, blockchain has just passed the peak of their hype cycle curve. If you read the news articles about it, one would think it has taken over the technology world. No disruptive technology is without its challenges and potential impediments t...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of San...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...